Literature DB >> 31820933

Binding and Reactivity of Copper to R1 and R3 Fragments of tau Protein.

Chiara Bacchella1, Silvia Gentili2, Denise Bellotti3, Eleonora Quartieri2, Sara Draghi4, Maria Camilla Baratto4, Maurizio Remelli3, Daniela Valensin4, Enrico Monzani1, Stefania Nicolis1, Luigi Casella1, Matteo Tegoni2, Simone Dell'Acqua1.   

Abstract

Tau protein is present in significant amounts in neurons, where it contributes to the stabilization of microtubules. Insoluble neurofibrillary tangles of tau are associated with several neurological disorders known as tauopathies, among which is Alzheimer's disease. In neurons, tau binds tubulin through its microtubule binding domain which comprises four imperfect repeats (R1-R4). The histidine residues contained in these fragments are potential binding sites for metal ions and are located close to the regions that drive the formation of amyloid aggregates of tau. In this study, we present a detailed characterization through potentiometric and spectroscopic methods of the binding of copper in both oxidation states to R1 and R3 peptides, which contain one and two histidine residues, respectively. We also evaluate how the redox cycling of copper bound to tau peptides can mediate oxidation that can potentially target exogenous substrates such as neuronal catecholamines. The resulting quinone oxidation products undergo oligomerization and can competitively give post-translational peptide modifications yielding catechol adducts at amino acid residues. The presence of His-His tandem in the R3 peptide strongly influences both the binding of copper and the reactivity of the resulting copper complex. In particular, the presence of the two adjacent histidines makes the copper(I) binding to R3 much stronger than in R1. The copper-R3 complex is also much more active than the copper-R1 complex in promoting oxidative reactions, indicating that the two neighboring histidines activate copper as a catalyst in molecular oxygen activation reactions.

Entities:  

Year:  2019        PMID: 31820933     DOI: 10.1021/acs.inorgchem.9b02266

Source DB:  PubMed          Journal:  Inorg Chem        ISSN: 0020-1669            Impact factor:   5.165


  5 in total

Review 1.  Amyloid Oligomers: A Joint Experimental/Computational Perspective on Alzheimer's Disease, Parkinson's Disease, Type II Diabetes, and Amyotrophic Lateral Sclerosis.

Authors:  Phuong H Nguyen; Ayyalusamy Ramamoorthy; Bikash R Sahoo; Jie Zheng; Peter Faller; John E Straub; Laura Dominguez; Joan-Emma Shea; Nikolay V Dokholyan; Alfonso De Simone; Buyong Ma; Ruth Nussinov; Saeed Najafi; Son Tung Ngo; Antoine Loquet; Mara Chiricotto; Pritam Ganguly; James McCarty; Mai Suan Li; Carol Hall; Yiming Wang; Yifat Miller; Simone Melchionna; Birgit Habenstein; Stepan Timr; Jiaxing Chen; Brianna Hnath; Birgit Strodel; Rakez Kayed; Sylvain Lesné; Guanghong Wei; Fabio Sterpone; Andrew J Doig; Philippe Derreumaux
Journal:  Chem Rev       Date:  2021-02-05       Impact factor: 60.622

Review 2.  Effect of metal ions on Alzheimer's disease.

Authors:  Fan Liu; Zhuo Zhang; Lin Zhang; Ruo-Ni Meng; Jia Gao; Ming Jin; Ming Li; Xiao-Peng Wang
Journal:  Brain Behav       Date:  2022-02-24       Impact factor: 2.708

Review 3.  Aβ and Tau Interact with Metal Ions, Lipid Membranes and Peptide-Based Amyloid Inhibitors: Are These Common Features Relevant in Alzheimer's Disease?

Authors:  Giuseppe Di Natale; Giuseppina Sabatino; Michele Francesco Maria Sciacca; Rita Tosto; Danilo Milardi; Giuseppe Pappalardo
Journal:  Molecules       Date:  2022-08-09       Impact factor: 4.927

4.  Oxidase Reactivity of CuII Bound to N-Truncated Aβ Peptides Promoted by Dopamine.

Authors:  Chiara Bacchella; Simone Dell'Acqua; Stefania Nicolis; Enrico Monzani; Luigi Casella
Journal:  Int J Mol Sci       Date:  2021-05-14       Impact factor: 5.923

5.  Copper and zinc isotopic excursions in the human brain affected by Alzheimer's disease.

Authors:  Frédéric Moynier; Marie Le Borgne; Esther Lahoud; Brandon Mahan; Francois Mouton-Liger; Jacques Hugon; Claire Paquet
Journal:  Alzheimers Dement (Amst)       Date:  2020-10-19
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.